跳至主要内容
临床试验/ACTRN12621000478819
ACTRN12621000478819招募中3 期

Efficacy of single versus split dose enoxaparin post elective neurointervention in prevention of thromboembolic events in adults- a randomised study

Royal Brisbane and Women's Hospital0 个研究点目标入组 124 人开始时间: 2021年4月21日最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
124

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Patients deemed fit for an elective endovascular aneurysm treatment
  • Patients who require post procedure anticoagulation after intracranial endovascular aneurysm treatment. The criteria for post procedural anticoagulation are any of the following:
  • 1) Placement of an Endovascular Device
  • 2) Presence of procedural platelet aggregation
  • 3) Increased risk of thromboembolic events due to
  • (3a) large area of coil exposure at aneurysm neck
  • (3b) loop protrusion into parent artery
  • Able to understand the project and provide voluntary consent and continued participation

排除标准

  • Patients under 18 years of age (i.e. paediatric population)
  • Patients presenting with acute subarachnoid haemorrhage
  • Patients with significantly impaired renal function (eGFR < 30)
  • Patients not suitable for 3T MR imaging (e.g. pacemakers)
  • Pregnant women
  • Patients deemed not to require anti-coagulation

研究者

相似试验